WILMINGTON, Mass.--(BUSINESS WIRE)--Jan. 18, 2006--Stiefel is the World’s Largest Independent Pharmaceutical Company Specializing in Dermatology. DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA), announced today that it has entered into an exclusive marketing, distribution and supply agreement for Latin America with Stiefel Laboratories, Inc, a market leader in prescription drugs in the region for dermatology. The agreement covers current and future uses of DUSA’s proprietary Levulan(R) Kerastick(R) for photodynamic therapy (PDT) in dermatology.
